GERN Q3 2017 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$163,000-96.8% YoY

Gross Profit

-$2M-1155.2% margin

Operating Income

-$7M-4444.2% margin

Net Income

-$7M-4232.5% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$114M

Total Liabilities

$6M

Stockholders' Equity

$108M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$163,000	$5M	-96.8%
Gross Profit	-$2M	$2M	-223.1%
Operating Income	-$7M	-$4M	-86.8%
Net Income	-$7M	-$4M	-92.9%